A Clinical Study of the C8 MediSensors Optical Glucose Monitor™
Spectrum
A Clinical Study to Evaluate the Performance of the C8 MediSensors Optical Glucose Monitor™ During On-Site Testing and Real Time Use Monitoring
1 other identifier
interventional
86
1 country
1
Brief Summary
The purpose of this study is to compare glucose measurements from the C8 MediSensors non-invasive Optical Glucose Monitor™ System to blood glucose measurements from the Yellow Springs Instrument(YSI) blood glucose analyzer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable diabetes-mellitus
Started Jun 2012
Shorter than P25 for not_applicable diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2012
CompletedFirst Submitted
Initial submission to the registry
October 31, 2012
CompletedFirst Posted
Study publicly available on registry
November 14, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2013
CompletedMarch 26, 2013
March 1, 2013
9 months
October 31, 2012
March 23, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Performance of the test device in comparison to the reference device
The primary objective is to characterize the accuracy of the non-invasive glucose measurements from the Optical Glucose Monitor™ to blood glucose measurements on a sample size of approximately 30 subjects with 1000 time matched, paired data points.
6 months
Study Arms (1)
Non-invasive Optical Glucose Monitor™
EXPERIMENTALTest device
Interventions
Test device
Reference device
Eligibility Criteria
You may qualify if:
- years of age or older.
- Understands and agrees to comply with study instructions.
- Read, understood, signed and dated the Informed Consent Form.
You may not qualify if:
- Pregnancy.
- Extensive skin changes or diseases that preclude wearing the test device at the proposed wear site(s) (e.g., extensive psoriasis, recent burns or severe sunburn, extensive eczema, extensive scarring, extensive tattoos, dermatitis herpetiformis).
- Employed by a company within the diabetes field other than the study sponsor.
- Medical history or any condition that may, in the opinion of the investigator, compromise the subject's ability to participate.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
C8 MediSensors, Inc.
San Jose, California, 95119, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vice President, Clincal, Regulatory, Quality
C8 MediSensors, Inc.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 31, 2012
First Posted
November 14, 2012
Study Start
June 1, 2012
Primary Completion
March 1, 2013
Study Completion
March 1, 2013
Last Updated
March 26, 2013
Record last verified: 2013-03